Potential Relevance of B-cell Maturation Pathways in Defining the Cell(s) of Origin for Chronic Lymphocytic Leukemia

被引：7
作者：
Ng, Anita [1 ,2 ]
Chiorazzi, Nicholas [1 ,2 ]
机构：
[1] Feinstein Inst Med Res, Karches Ctr Oncol Res, Inst Mol Med, 350 Community Dr, Manhasset, NY 11030 USA
[2] Donald & Barbara Zucker Sch Med Hofstra Northwell, 350 Community Dr, Manhasset, NY 11030 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2021年 / 35卷 / 04期
关键词：
Chronic lymphocytic leukemia; Cell of origin; Normal counterparts; B lymphocytes; B-cell maturation pathways; CYTIDINE DEAMINASE EXPRESSION; CLASS SWITCH RECOMBINATION; DNA METHYLATION DYNAMICS; HEMATOPOIETIC STEM-CELL; GERMINAL CENTER B; V-H GENES; MEMORY B; ANTIGEN RECEPTORS; B-1A CELLS; TERMINAL DIFFERENTIATION;
D O I：
10.1016/j.hoc.2021.03.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：665 / 685
页数：21
相关论文
共 50 条
[41]   IGG SUBCLASS LEVELS IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA [J].
COPSON, ER ;
ELLIS, BA ;
WESTWOOD, NB ;
MAJUMDAR, G .
LEUKEMIA & LYMPHOMA, 1994, 14 (5-6) :471-473
[42]   Cytogenetic and molecular cytogenetic investigations in relapse of B-cell chronic lymphocytic leukemia [J].
S. V. Andreieva ;
K. V. Korets ;
I. M. Skorokhod ;
O. E. Ruzhinska .
Cytology and Genetics, 2017, 51 :155-161
[43]   Bilateral cauliflower ear as the presenting sign of B-cell chronic lymphocytic leukemia [J].
Kindem, S. ;
Traves, V. ;
Requena, C. ;
Alcala, R. ;
Llombart, B. ;
Serra-Guillen, C. ;
Nagore, E. ;
Guillen, C. ;
Sanmartin, O. .
JOURNAL OF CUTANEOUS PATHOLOGY, 2014, 41 (02) :73-77
[44]   Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL) [J].
Montillo, Marco ;
Ricci, Francesca ;
Miqueleiz, Sara ;
Tedeschi, Alessandra ;
Morra, Enrica .
BIOLOGICS-TARGETS & THERAPY, 2008, 2 (01) :41-52
[45]   Karyotype complexity and VH gene status in B-cell chronic lymphocytic leukemia [J].
Mehes, Gabor ;
Kovacs, Gabor ;
Kajtar, Bela ;
Lacza, Agnes ;
Varnai, Alinda ;
Losonczy, Hajna ;
Pajor, Laszlo .
HAEMATOLOGICA, 2006, 91 (10) :1430-1431
[46]   Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance [J].
Michele Dal-Bo ;
Francesco Bertoni ;
Francesco Forconi ;
Antonella Zucchetto ;
Riccardo Bomben ;
Roberto Marasca ;
Silvia Deaglio ;
Luca Laurenti ;
Dimitar G Efremov ;
Gianluca Gaidano ;
Giovanni Del Poeta ;
Valter Gattei .
Journal of Translational Medicine, 7
[47]   Pathophysiology of chronic lymphocytic leukemia and human B1 cell development [J].
Kikushige, Yoshikane .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 111 (05) :634-641
[48]   MEASUREMENT OF THE INTENSITY OF CELL-SURFACE ANTIGEN EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA [J].
WITZIG, TE ;
LI, CY ;
TEFFERI, A ;
KATZMANN, JA .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1994, 101 (03) :312-317
[49]   B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma involving bone marrow with an interfollicular pattern [J].
Kim, YS ;
Ford, RJ ;
Faber, JA ;
Bell, RH ;
Elenitoba-Johnson, KSJ ;
Medeiros, LJ .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (01) :41-46
[50]   Idelalisib therapy of indolent B-cell malignancies: chronic lymphocytic leukemia and small lymphocytic or follicular lymphomas [J].
Madanat, Yazan F. ;
Smith, Mitchell R. ;
Almasan, Alexandru ;
Hill, Brian T. .
BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2016, 6 :1-6
12345